Showing results (51-60 of 3,415) with videos related to

Sort By:
Pageof 342
Prehospital Emergency Care|May 11, 2017
Prehospital Intubation is Associated with Favorable Outcomes and Lower Mortality in ProTECT IIIKurt R Denninghoff, Tomas Nuño, Qi Pauls, et al.
Clinical Trials (London, England)|January 21, 2006
Non-linearity of Parkinson's disease progression: implications for sample size calculations in clinical trialsPaulo Guimaraes, Karl Kieburtz, Christopher G Goetz, et al.
The Journal of Rheumatology|May 1, 1997
Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparisonH R Maricq, P H Carpentier, M C Weinrich, et al.
JAMA Neurology|April 30, 2019
Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical TrialHolly Tillman, S Claiborne Johnston, Mary Farrant, et al.
Stroke|November 30, 2016
Power of an Adaptive Trial Design for Endovascular Stroke Studies: Simulations Using IMS (Interventional Management of Stroke) III DataMaarten G Lansberg, Ninad S Bhat, Sharon D Yeatts, et al.
The New England Journal of Medicine|May 17, 2018
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIAS Claiborne Johnston, J Donald Easton, Mary Farrant, et al.
Stroke|May 7, 2011
The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysisMichael D Hill, Renee H Martin, Yuko Y Palesch, et al.
Stroke|December 18, 2010
The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2Myron D Ginsberg, Yuko Y Palesch, Renee H Martin, et al.
Plos One|September 2, 2015
Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter TrialMichael D Hill, Renee H Martin, Yuko Y Palesch, et al.
Neurology|March 15, 2006
Optimizing the ongoing search for new treatments for Parkinson disease: using futility designsB C Tilley, Y Y Palesch, K Kieburtz, et al.
Pageof 342